Weaver DF and Barden C, overlook the rigorously reviewed novel work in ‘Don't patents’ (2009) 461 Nature 340 Webb and others, Unobtrusive Measures: Non-reactive Research in the Social Sciences (Rand McNally 1966) Wellcome Trust, under which a grant is awarded’ <> accessed 10 April ‘Conditions 2014 on intellectual property and patenting <> accessed 10 April 2014 –––, ‘Policy ’ Trust-funded intellectual property: exploitation consent and standard –––, ‘Wellcome revenue/equity-sharing agreement (CRSA/12/2009)’ < > accessed 11 April 2014 Wellings P, Intellectual property and research benefits (BIS 2008) Wilson T, (BIS 2012) A Review of Business-University Collaboration WIPO, for which PCT national phase information is available in ‘Offices PATENTSCOPE Search Service’ <> accessed 05 April 2014 Content of the Database’ < > accessed 05 April 2014 –––, ‘PATENTSCOPE Yamanaka S, Nuclear Reprogramming Factor (EP 1 970 446) (2011) Zarzeczny A and others, Cells: Mapping the Policy Issues’ (2009) 139 Cell 1032 ‘iPS Anonymous sources case: Myriad at the Supreme Court (Fitzpatrick Cella Haper & Scinto LLP)’ ‘The (2013) <> accessed 13 April 2014 Dynamics International IPO (as filed with the Securities and Exchange ‘Cellular Commission on June 3, 2013. Registration No. 333)’ (2013) <> accessed 05 April 2014 to patent’ <> accessed 13 April 2014 ‘Peer Medicine Expert <https://> accessed 10 April 2014 ‘Regenerative for ex reexamination patent number 5, 843, 780 Primate Embryonic ‘Request Stem Cells’ (2006) <> accessed 13 April 2014
Weaver DF and Barden C, ‘Don't overlook the rigorously reviewed novel work in patents’ (2009) 461 Nature 340 Webb and others, Unobtrusive Measures: Non-reactive Research in the Social Sciences (Rand McNally 1966) Wellcome Trust, ‘Conditions under which a grant is awarded’ <> accessed 10 April 2014 –––, ‘Policy on intellectual property and patenting ’ <> accessed 10 April 2014 –––, ‘Wellcome Trust-funded intellectual property: exploitation consent and standard revenue/equity-sharing agreement (CRSA/12/2009)’ < > accessed 11 April 2014 Wellings P, Intellectual property and research benefits (BIS 2008) Wilson T, A Review of Business-University Collaboration (BIS 2012) WIPO, ‘Offices for which PCT national phase information is available in PATENTSCOPE Search Service’ <> accessed 05 April 2014 –––, ‘PATENTSCOPE Content of the Database’ < > accessed 05 April 2014 Yamanaka S, Nuclear Reprogramming Factor (EP 1 970 446) (2011) Zarzeczny A and others, ‘iPS Cells: Mapping the Policy Issues’ (2009) 139 Cell 1032 Anonymous sources ‘The case: Myriad at the Supreme Court (Fitzpatrick Cella Haper & Scinto LLP)’ (2013) <> accessed 13 April 2014 ‘Cellular Dynamics International IPO (as filed with the Securities and Exchange Commission on June 3, 2013. Registration No. 333)’ (2013) <> accessed 05 April 2014 ‘Peer to patent’ <> accessed 13 April 2014 ‘Regenerative Medicine Expert <https://> accessed 10 April 2014 ‘Request for ex reexamination patent number 5, 843, 780 Primate Embryonic Stem Cells’ (2006) <> accessed 13 April 2014
Anna%20Hescott%20Thesis.docx